Document Detail

2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells.
MedLine Citation:
PMID:  23283523     Owner:  NLM     Status:  Publisher    
Since epithelial-mesenchymal transition (EMT) plays a critical role in cancer progression and in maintaining cancer stem cell properties, EMT is emerging as a therapeutic target for inhibiting the metastatic progression of cancer cells. 2'-Hydroxycinnamaldehyde (HCA) and its derivative, 2'-benzoyloxycinnamaldehyde, have recently been suggested as promising therapeutic candidates for cancer treatment. The purpose of this study is to investigate the anti-metastatic effect of HCA on breast cancer and the molecular mechanisms by which HCA regulates the transcriptional program during EMT. HCA induces epithelial reversion at nanomolar concentrations by suppressing Snail via the nuclear translocalization of GSK-3β, which results in the transcriptional upregulation of E-cadherin. HCA also activates the transcription factor KLF17, which suppresses Id-1, indicating that HCA inhibits EMT by multiple transcriptional programs. Further, HCA treatment significantly inhibits lung metastasis in a mouse orthotopic breast cancer model. This study demonstrates the anti-metastatic effect of the non-toxic natural compound HCA through attenuation of EMT in a breast cancer model.
Ismail Ahmed Ismail; Hye Sook Kang; Heon-Jin Lee; Hyeyoun Chang; Jieun Yun; Chang Woo Lee; Nam Hee Kim; Hyun Sil Kim; Jong In Yook; Su-Hyung Hong; Byoung-Mog Kwon
Related Documents :
18777593 - Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient ap...
24415643 - Programmed cell death 1-directed immunotherapy for enhancing t-cell function.
21949223 - Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabet...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-3
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  -     ISSN:  1573-7217     ISO Abbreviation:  Breast Cancer Res. Treat.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Oral Microbiology, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multifunctional enzymes in archaea: promiscuity and moonlight.
Next Document:  Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.